EQIX
59
2
BAC
56
2
PNR
53
3
ISRG
67
5
TROW
37
5
GME
66
-2
HRB
37
2
V
50
2
MOS
48
-2
AIV
44
-3
CFG
60
2
HD
37
2
MTCH
42
-4
ADSK
61
4
PPL
49
2
O
20
-8
MU
52
-6
DAL
64
3
TGT
54
-3
AMP
52
6
EQIX
59
2
BAC
56
2
PNR
53
3
ISRG
67
5
TROW
37
5
GME
66
-2
HRB
37
2
V
50
2
MOS
48
-2
AIV
44
-3
CFG
60
2
HD
37
2
MTCH
42
-4
ADSK
61
4
PPL
49
2
O
20
-8
MU
52
-6
DAL
64
3
TGT
54
-3
AMP
52
6
Financhill
Back

CBRE Group Vs. Collegium Pharmaceutical Industry Stock Comparison

Buy
67

CBRE
CBRE Group

Last Price:
$129.84
Seasonality Move:
8.61%
Sell
45

COLL
Collegium Pharmaceutical

Last Price:
$33.33
Seasonality Move:
-1.63%
Buy
67
CBRE Group (CBRE) is a Buy

Is CBRE Group a Buy, Sell or Hold?

  • The current CBRE Group [CBRE] share price is $129.78. The Score for CBRE is 67, which is 34% above its historic median score of 50, and infers lower risk than normal.
  • CBRE is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
45
Collegium Pharmaceutical (COLL) is a Sell

Is Collegium Pharmaceutical a Buy, Sell or Hold?

  • The current Collegium Pharmaceutical [COLL] share price is $33.34. The Score for COLL is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
  • COLL is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

CBRE Stock Price Chart

What is CBRE Group's stock price today?

  • The CBRE Group share price today is $129.78
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CBRE is experiencing buying pressure, which is a positive indicator for future bullish movement.

COLL Stock Price Chart

What is Collegium Pharmaceutical's stock price today?

  • The Collegium Pharmaceutical share price today is $33.34
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and COLL is experiencing buying pressure, which is a positive indicator for future bullish movement.

CBRE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.11 Sell
Relative Strength Index (14 RSI): 44.68 Sell
Chaikin Money Flow: 1318349 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (129.49 - 137.17) Sell
Bollinger Bands (100): (118.27 - 134.87) Buy

COLL Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.27 Sell
Relative Strength Index (14 RSI): 66.05 Buy
Chaikin Money Flow: 1007158 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (28.9 - 30.94) Buy
Bollinger Bands (100): (30.52 - 37.92) Sell

CBRE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 130.55 Sell
20-day SMA: 132.34 Sell
50-day SMA: 133.64 Sell
200-day SMA: 109.78 Buy
8-day EMA: 130.57 Sell
20-day EMA: 131.86 Sell
50-day EMA: 131.18 Sell
200-day EMA: 114.54 Buy

COLL Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 29.45 Buy
20-day SMA: 29.79 Buy
50-day SMA: 30.91 Buy
200-day SMA: 34.47 Sell
8-day EMA: 30.02 Buy
20-day EMA: 29.94 Buy
50-day EMA: 31.21 Buy
200-day EMA: 32.94 Buy

CBRE Group Earnings Growth & CBRE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.45 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.13 per share, and an increase next year of $1.08 per share.

Collegium Pharmaceutical Earnings Growth & COLL Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.11 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.42 per share, and an increase next year of $0.51 per share.

CBRE Group Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Collegium Pharmaceutical Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):